{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:34:54Z","timestamp":1770212094775,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"DOI":"10.7759\/cureus.102923","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T02:59:41Z","timestamp":1770173981000},"source":"Crossref","is-referenced-by-count":0,"title":["A Novel SLC9A3R1 Mutation as a Rare Cause of Infantile Hypercalcemia"],"prefix":"10.7759","author":[{"given":"Padala","family":"Ravi Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankeet","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak K","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debasish","family":"Patro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Sai","family":"Madhav Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05082-z","article-title":"Genetic causes of neonatal and infantile hypercalcaemia","volume":"37","author":"Gorvin CM","year":"2022","unstructured":"Gorvin CM. Genetic causes of neonatal and infantile hypercalcaemia. Pediatr Nephrol. 2022, 37:289-301. 10.1007\/s00467-021-05082-z","journal-title":"Pediatr Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3105","article-title":"Determination of reference intervals for serum total calcium in the vitamin D-replete pediatric population","volume":"98","author":"Roizen JD","year":"2013","unstructured":"Roizen JD, Shah V, Levine MA, Carlow DC. Determination of reference intervals for serum total calcium in the vitamin D-replete pediatric population. J Clin Endocrinol Metab. 2013, 98:E1946-50. 10.1210\/jc.2013-3105","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-62520-3.00020-8","article-title":"Disorders of mineral metabolism II: abnormalities of mineral homeostasis in the newborn, infant, child, and adolescent","author":"Root AW","year":"2021","unstructured":"Root AW, Levine MA. Disorders of mineral metabolism II: abnormalities of mineral homeostasis in the newborn, infant, child, and adolescent. Sperling Pediatric Endocrinology, 5th Edition. Sperling MA (ed): Elsevier, Philadelphia, PA; 2021. 705-813. 10.1016\/B978-0-323-62520-3.00020-8"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3296","article-title":"Hypercalcemic disorders in children","volume":"32","author":"Stokes VJ","year":"2017","unstructured":"Stokes VJ, Nielsen MF, Hannan FM, Thakker RV. Hypercalcemic disorders in children. J Bone Miner Res. 2017, 32:2157-70. 10.1002\/jbmr.3296","journal-title":"J Bone Miner Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann KP","year":"2016","unstructured":"Schlingmann KP, Ruminska J, Kaufmann M, et al.. Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol. 2016, 27:604-14. 10.1681\/ASN.2014101025","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad001","article-title":"High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture","volume":"188","author":"Marini F","year":"2023","unstructured":"Marini F, Giusti F, Marasco E, et al.. High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture. Eur J Endocrinol. 2023, 188:lvad001. 10.1093\/ejendo\/lvad001","journal-title":"Eur J Endocrinol"},{"key":"ref7","unstructured":"ClinVar. (2026). Accessed. February 3, 2026: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802836","article-title":"NHERF1 mutations and responsiveness of renal parathyroid hormone","volume":"359","author":"Karim Z","year":"2008","unstructured":"Karim Z, G\u00e9rard B, Bakouh N, et al.. NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med. 2008, 359:1128-35. 10.1056\/NEJMoa0802836","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.06.025","article-title":"Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and\u00a0nephrocalcinosis","volume":"93","author":"Daga A","year":"2018","unstructured":"Daga A, Majmundar AJ, Braun DA, et al.. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and\u00a0nephrocalcinosis. Kidney Int. 2018, 93:204-13. 10.1016\/j.kint.2017.06.025","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014040388","article-title":"Fourteen monogenic genes account for 15% of nephrolithiasis\/nephrocalcinosis","volume":"26","author":"Halbritter J","year":"2015","unstructured":"Halbritter J, Baum M, Hynes AM, et al.. Fourteen monogenic genes account for 15% of nephrolithiasis\/nephrocalcinosis. J Am Soc Nephrol. 2015, 26:543-51. 10.1681\/ASN.2014040388","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-005-1021-2","article-title":"The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease","volume":"371","author":"van Abel M","year":"2005","unstructured":"van Abel M, Hoenderop JG, Bindels RJ. The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease. Naunyn Schmiedebergs Arch Pharmacol. 2005, 371:295-306. 10.1007\/s00210-005-1021-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-301284","article-title":"Investigation and management of hypercalcaemia in children","volume":"97","author":"Davies JH","year":"2012","unstructured":"Davies JH, Shaw NJ. Investigation and management of hypercalcaemia in children. Arch Dis Child. 2012, 97:533-8. 10.1136\/archdischild-2011-301284","journal-title":"Arch Dis Child"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2023-0212","article-title":"Successful treatment of hypercalcemia in a Chinese patient with a novel homozygous mutation in the CYP24A1 gene using zoledronic acid: a case report","volume":"36","author":"Zheng Z","year":"2023","unstructured":"Zheng Z, Wu Y, Wu H, Jin J, Luo Y, Cao S, Shan X. Successful treatment of hypercalcemia in a Chinese patient with a novel homozygous mutation in the CYP24A1 gene using zoledronic acid: a case report. J Pediatr Endocrinol Metab. 2023, 36:886-9. 10.1515\/jpem-2023-0212","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv028","article-title":"Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole","volume":"8","author":"Sayers J","year":"2015","unstructured":"Sayers J, Hynes AM, Srivastava S, Dowen F, Quinton R, Datta HK, Sayer JA. Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole. Clin Kidney J. 2015, 8:453-5. 10.1093\/ckj\/sfv028","journal-title":"Clin Kidney J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2023.106301","article-title":"Rifampin monotherapy for children with idiopathic infantile hypercalcemia","volume":"231","author":"Lenherr-Taube N","year":"2023","unstructured":"Lenherr-Taube N, Furman M, Assor E, Thummel K, Levine MA, Sochett E. Rifampin monotherapy for children with idiopathic infantile hypercalcemia. J Steroid Biochem Mol Biol. 2023, 231:106301. 10.1016\/j.jsbmb.2023.106301","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1319","article-title":"Approach to the hypophosphatemic patient","volume":"97","author":"Imel EA","year":"2012","unstructured":"Imel EA, Econs MJ. Approach to the hypophosphatemic patient. J Clin Endocrinol Metab. 2012, 97:696-706. 10.1210\/jc.2011-1319","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455694-a-novel-slc9a3r1-mutation-as-a-rare-cause-of-infantile-hypercalcemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T02:59:42Z","timestamp":1770173982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455694-a-novel-slc9a3r1-mutation-as-a-rare-cause-of-infantile-hypercalcemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.102923","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}